Published in TB and Outbreaks Week, August 4th, 2009
"The screens identified partially overlapping sets of compounds that were further characterized for affinity, mechanism, and efficacy in additional...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.